Bolt Biotherapeutics Inc
BOLT5.620USD
+0.090+1.63%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
10.77MMarket Cap
LossP/E TTM
Bolt Biotherapeutics Inc
5.620
+0.090+1.63%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
Total revenue
-76.83%1.22M
-100.00%0.00
-54.87%1.14M
-11.03%1.27M
188.83%5.27M
48.05%2.09M
19.70%2.53M
2.87%1.43M
124.60%1.83M
177.76%1.41M
180.85%2.11M
--1.39M
--813.00K
--508.00K
--752.00K
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--67.00K
--164.00K
--65.00K
--121.00K
Revenue
-76.83%1.22M
-100.00%0.00
-54.87%1.14M
-11.03%1.27M
188.83%5.27M
48.05%2.09M
19.70%2.53M
2.87%1.43M
124.60%1.83M
177.76%1.41M
180.85%2.11M
--1.39M
--813.00K
--508.00K
--752.00K
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
--67.00K
--164.00K
--65.00K
--121.00K
Operating expenses
-40.37%13.34M
-28.30%15.67M
-15.10%17.58M
-4.51%20.31M
10.50%22.37M
-2.65%21.86M
-15.32%20.71M
-13.03%21.27M
-18.02%20.24M
-18.61%22.45M
0.74%24.46M
2.91%24.45M
33.99%24.69M
63.00%27.58M
95.71%24.28M
112.59%23.76M
106.82%18.43M
76.79%16.92M
64.57%12.40M
--11.18M
--8.91M
--9.57M
--7.54M
R&D expenses
-42.45%9.51M
-28.18%11.72M
-7.80%13.79M
-1.35%15.43M
13.02%16.53M
-3.10%16.32M
-21.20%14.95M
-17.32%15.64M
-20.45%14.63M
-25.08%16.84M
-1.88%18.97M
-3.99%18.92M
30.14%18.39M
51.26%22.48M
102.69%19.34M
115.00%19.71M
108.15%14.13M
99.92%14.86M
52.93%9.54M
--9.17M
--6.79M
--7.43M
--6.24M
Depreciation, depletion, and amortization
-12.88%399.00K
-8.78%426.00K
8.23%500.00K
-0.22%457.00K
-1.93%458.00K
-6.60%467.00K
5.24%462.00K
12.25%458.00K
16.75%467.00K
25.00%500.00K
44.41%439.00K
59.38%408.00K
33.33%400.00K
81.00%400.00K
52.00%304.00K
132.73%256.00K
197.03%300.00K
121.00%221.00K
135.29%200.00K
--110.00K
--101.00K
--100.00K
--85.00K
Operating profit
29.12%-12.12M
20.73%-15.67M
9.57%-16.44M
4.03%-19.03M
7.18%-17.09M
6.06%-19.77M
18.63%-18.18M
13.99%-19.83M
22.87%-18.41M
22.29%-21.04M
5.02%-22.35M
2.95%-23.06M
-29.58%-23.88M
-60.00%-27.07M
-89.65%-23.53M
-113.87%-23.76M
-110.70%-18.43M
-78.00%-16.92M
-67.25%-12.40M
---11.11M
---8.74M
---9.51M
---7.42M
Net non-operating interest income (expenses)
Non-operating interest income
-34.43%1.05M
-47.40%980.00K
-34.22%1.27M
-21.01%1.40M
11.92%1.61M
78.62%1.86M
228.11%1.93M
349.37%1.77M
624.75%1.44M
--1.04M
348.09%587.00K
124.43%395.00K
253.57%198.00K
----
445.83%131.00K
245.10%176.00K
-50.00%56.00K
-91.72%12.00K
-89.66%24.00K
--51.00K
--112.00K
--145.00K
--232.00K
Special income (expenses)
-99.53%22.00K
---1.25M
--0.00
---3.56M
--4.67M
----
----
----
----
--0.00
--0.00
--0.00
100.00%0.00
100.00%0.00
-100.00%0.00
--0.00
---6.08M
---14.13M
237900.00%2.38M
--0.00
--0.00
--0.00
--1.00K
Other non-operating income (expenses)
----
----
--0.00
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income before tax
-2.12%-11.04M
10.99%-15.94M
6.65%-15.18M
-17.38%-21.20M
36.33%-10.81M
10.47%-17.90M
25.29%-16.26M
20.33%-18.06M
28.29%-16.98M
26.37%-20.00M
6.99%-21.76M
3.91%-22.66M
3.17%-23.68M
12.50%-27.16M
-133.93%-23.39M
-113.27%-23.59M
-183.26%-24.45M
-231.50%-31.04M
-39.21%-10.00M
---11.06M
---8.63M
---9.36M
---7.18M
Income tax
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income after tax
-2.12%-11.04M
10.99%-15.94M
6.65%-15.18M
-17.38%-21.20M
36.33%-10.81M
10.47%-17.90M
25.29%-16.26M
20.33%-18.06M
28.29%-16.98M
26.37%-20.00M
6.99%-21.76M
3.91%-22.66M
3.17%-23.68M
12.50%-27.16M
-133.93%-23.39M
-113.27%-23.59M
-183.26%-24.45M
-231.50%-31.04M
-39.21%-10.00M
---11.06M
---8.63M
---9.36M
---7.18M
Net income from continuous operations
-2.12%-11.04M
10.99%-15.94M
6.65%-15.18M
-17.38%-21.20M
36.33%-10.81M
10.47%-17.90M
25.29%-16.26M
20.33%-18.06M
28.29%-16.98M
26.37%-20.00M
6.99%-21.76M
3.91%-22.66M
3.17%-23.68M
12.50%-27.16M
-133.93%-23.39M
-113.27%-23.59M
-183.26%-24.45M
-231.50%-31.04M
-39.21%-10.00M
---11.06M
---8.63M
---9.36M
---7.18M
Net income attributable to controlling interests
-2.12%-11.04M
10.99%-15.94M
6.65%-15.18M
-17.38%-21.20M
36.33%-10.81M
10.47%-17.90M
25.29%-16.26M
20.33%-18.06M
28.29%-16.98M
26.37%-20.00M
6.99%-21.76M
3.91%-22.66M
3.17%-23.68M
12.50%-27.16M
-133.93%-23.39M
-113.27%-23.59M
-183.26%-24.45M
-231.50%-31.04M
-39.21%-10.00M
---11.06M
---8.63M
---9.36M
---7.18M
Net income attributable to common shareholders
-2.12%-11.04M
10.99%-15.94M
6.65%-15.18M
-17.38%-21.20M
36.33%-10.81M
10.47%-17.90M
25.29%-16.26M
20.33%-18.06M
28.29%-16.98M
26.37%-20.00M
6.99%-21.76M
3.91%-22.66M
3.17%-23.68M
12.50%-27.16M
-133.93%-23.39M
-113.27%-23.59M
-183.26%-24.45M
-231.50%-31.04M
-39.21%-10.00M
---11.06M
---8.63M
---9.36M
---7.18M
Basic earnings per share
-1.39%-0.29
11.79%-0.42
7.58%-0.40
-16.21%-0.56
36.97%-0.28
11.39%-0.47
26.10%-0.43
21.29%-0.48
29.35%-0.45
26.67%-0.53
7.61%-0.58
5.70%-0.61
43.93%-0.64
2.33%-0.73
-117.05%-0.63
-101.18%-0.64
-354.86%-1.14
-174.13%-0.74
-39.21%-0.29
---0.32
---0.25
---0.27
---0.21
Diluted earnings per share
-1.39%-0.29
11.79%-0.42
7.58%-0.40
-16.21%-0.56
36.97%-0.28
11.39%-0.47
26.10%-0.43
21.29%-0.48
29.35%-0.45
26.67%-0.53
7.61%-0.58
5.70%-0.61
43.93%-0.64
2.33%-0.73
-117.05%-0.63
-101.18%-0.64
-354.86%-1.14
-174.13%-0.74
-39.21%-0.29
---0.32
---0.25
---0.27
---0.21
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
